TAVR procedures with a higher implant depth are associated with certain clinical benefits after one year, according to a new study of data from more than 600 patients. TAVR procedures with a higher implant depth are associated with certain clinical benefits after one year, according to a new study of data from more than 600 patients. | | |
|
Kenneth Bilchick, MD, spoke to Cardiovascular Business about new data he presented at Heart Rhythm 2026. Kenneth Bilchick, MD, spoke to Cardiovascular Business about new data he presented at Heart Rhythm 2026. | | |
|
LVOT obstruction is a serious complication of TMVR. BATMAN may help protect patients from LVOT obstruction without leading to any additional risks. LVOT obstruction is a serious complication of TMVR. BATMAN may help protect patients from LVOT obstruction without leading to any additional risks. | | |
|
|
The FDA has identified another safety concern with Johnson & Johnson MedTech's Automated Impella Controllers. This comes after the devices were linked to five separate recalls in 2025. The FDA has identified another safety concern with Johnson & Johnson MedTech's Automated Impella Controllers. This comes after the devices were linked to five separate recalls in 2025. | | |
|
The Alliance for Aging Research wants CMS to go through with policy changes that could make many more patients eligible for TAVR. The agency is currently considering the changes, and a final decision is expected in June. The Alliance for Aging Research wants CMS to go through with policy changes that could make many more patients eligible for TAVR. The agency is currently considering the changes, and a final decision is expected in June. | | |
|
"Pulmonary embolism is fundamentally a cardiovascular disease, where restoration of hemodynamic stability, beyond simple clot removal, is the key determinant of patient recovery,” one researcher explained. "Pulmonary embolism is fundamentally a cardiovascular disease, where restoration of hemodynamic stability, beyond simple clot removal, is the key determinant of patient recovery,” one researcher explained. | | |
|
This Class II recall includes more than 18,000 cannulae used during cardiac surgery. This Class II recall includes more than 18,000 cannulae used during cardiac surgery. | | |
|
|
Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes. Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes. | | |
|
Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications. Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications. | | |
|
When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival. When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival. | | |
|
|
The U.S. Department of Justice says its investigation into the scheme to defraud Amtrak’s employee health plan resulted in 19 prosecutions, all resulting in guilty pleas. For her role in over $2.2M of fraudulent billing, physical therapist Taejin Kim will serve a year in prison. The U.S. Department of Justice says its investigation into the scheme to defraud Amtrak’s employee health plan resulted in 19 prosecutions, all resulting in guilty pleas. For her role in over $2.2M of fraudulent billing, physical therapist Taejin Kim will serve a year in prison. | | |
|
In early 2025 public health researchers at City University of New York projected Long COVID would cost the U.S. $6.6 billion over three years. This week two members of that research team amplified their findings and updated their projections. In early 2025 public health researchers at City University of New York projected Long COVID would cost the U.S. $6.6 billion over three years. This week two members of that research team amplified their findings and updated their projections. | | |
|
